Direct Oral Anticoagulants – NHS Contract
23 July 2021 - 9:22 pm
Published yesterday (22nd July 2021) the UK Government contracts finder website has an opportunity for a supplier to provide £3,185,000,000 (yes, three billion, one hundred and eighty five million pounds) worth of “Novel Oral Anticoagulants”.
The time period for this sudden demand for treatments to tackle blood clotting is 01/11/2021 – 31/04/2024, with the possibility of extending that for another 12 months if the Authority deems it necessary.
As the issue of blood clots surrounding the experimental COVID injections that in March 2021 didn’t exist at all, then by April 2021 were “extremely rare” according to the bought and paid for mouthpieces, you could be forgiven for wondering why the sudden huge demand for anticoagulants, and if the progress from “no connection”, to “extremely rare” might follow that trend and thus require a large influx of the specific medication needed to treat blood clotting.
Of course, we should keep in mind that this is just as likely to be another payment to allies of the Government of over £3 billion of public money with no intention of helping or providing anything. This has already happened with the contract awarded to GenPact UK for a system to replace the Yellow Card reporting system worth £1,500,000 which is pocket change in comparison, but illustrates the point that these contracts go to supporters of the agenda with no actual expectation that it is considered money well spent or that the public will see any material benefit from these colossal sums of money flying around.
Purchasing thin air with money printed out of thin air seems to be the fiscal policy of the UK Government. The problem is it is the hard work of current and future generations that is expected to pay it back via taxes. Unless we collectively agree to stop paying for thin air.